Similar results were also emulated in preclinical studies with the combination of an AKT inhibitor MK-2206 and imatinib in GIST xenografts,28 thus highlighting the importance of PI3K inhibitors in advanced GIST. Here, AKT1 is linked to gastrointestinal stromal tumor.